FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to RGD-containing cyclic peptidomimetics, conjugates of the said peptidomimetics and a functional group, selected from fluorescent probes, photosensitisers, chelating agents or cytotoxic agents; and to pharmaceutical compositions, which contain the said conjugates.
EFFECT: conjugates by the invention are suitable both for diagnostic purposes and for treatment of different diseases, disorders and states.
26 cl, 9 dwg, 10 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF RGD-PEPTIDES AND PHOTOSENSITISERS OF PORPHYRIN OR (BACTERIO)CHLOROPHYLL AND APPLICATION THEREOF | 2007 |
|
RU2450018C2 |
| RGD-(BACTERIO)CHLOROPHYLL CONJUGATES FOR PHOTODYNAMIC THERAPY AND NECROTIC TUMOUR IMAGING | 2009 |
|
RU2518296C2 |
| RGD-CONTAINING PEPTIDES | 2001 |
|
RU2214416C2 |
| INHIBITORS OF VIIA FACTOR | 1999 |
|
RU2223967C2 |
| CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
| PEPTIDES MARKED WITH RADIOACTIVE ISOTOPES FOR DIAGNOSING AND TREATING DISEASES | 1996 |
|
RU2171117C2 |
| CYLLOPEPTIDE DERIVATIVES | 1996 |
|
RU2174520C2 |
| BOMBESIN ANALOGUE PEPTIDE ANTAGONIST CONJUGATES | 2009 |
|
RU2523531C2 |
| NEW PSA-BINDING AGENTS AND THEIR USE | 2018 |
|
RU2787105C2 |
| HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS | 2008 |
|
RU2450017C2 |
